z-logo
open-access-imgOpen Access
Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant
Author(s) -
Gabriel Mircus,
Shelly Hagag,
Emma Levdansky,
Haggai Sharon,
Yona Shadkchan,
Itamar Shalit,
Nir Osherov
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp270
Subject(s) - aspergillus nidulans , aspergillus fumigatus , cell wall , caspofungin , antifungal drug , mutant , biology , microbiology and biotechnology , candida albicans , biochemistry , voriconazole , antifungal , gene
Despite the need for novel drugs to combat fungal infections, antifungal drug discovery is currently limited by both the availability of suitable drug targets and assays to screen corresponding targets. The aim of this study was to screen a library of small chemical compounds to identify cell wall inhibitors using a conditional protein kinase C (PKC)-expressing strain of Aspergillus nidulans. This mutant is specifically susceptible to cell wall damaging compounds under PKC-repressive growth conditions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom